4: Statement of changes in beneficial ownership of securities-Officer Byrnes Michael
4: Statement of changes in beneficial ownership of securities-Officer WORLAND STEPHEN T
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Carlyle Group Inc.(4.1%),Carlyle Holdings I GP Inc.(4.1%), etc.
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bhatt Elizabeth
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ehrlich Christopher B
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Klencke Barbara
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Harrington-Smith Kristen
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gallagher Brian M. Jr.
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Byrnes Michael
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warner Douglas J
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WORLAND STEPHEN T
eFFECTOR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PFIZER INC.(3.47%),PFIZER STRATEGIC INVESTMENT HOLDINGS LLC(2.91%), etc.
eFFECTOR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
eFFECTOR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SR One Capital Management, LLC(0%),SR One Capital Fund I Aggregator, LP(0%), etc.
eFFECTOR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Altitude Life Science Ventures II, LLC(4.4%),David Maki(4.4%), etc.
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner SR ONE CAPITAL MANAGEMENT, LLC
eFFECTOR Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Column Group II, LP(0%),The Column Group II GP, LP(0%), etc.
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer WORLAND STEPHEN T
eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Byrnes Michael
No Data